IndiaSite.com
  facebook twitter linkedin wordpress wordpress wordpress  









Home / Companies in India > Zenotech Laboratories

Zenotech Laboratories

(Become first to Rate this Company!)
Zenotech Laboratories

Zenotech Laboratories Limited is an India-based company. The Company is engaged in the manufacture and trading of pharmaceuticals in India. As of March 31, 2010, the Company launched 15 generic chemical oncology products in India. It has three generic biological products, which include recombinant human granulocyte macrophage-colony stimulating factor (GM-CSF), recombinant human granulocyte colony stimulating factor (G-CSF) and Interlukin-2. All the three are used in cancer therapy. Its principal products include Gemcitabine, Paclitaxel and Docetaxel. 
         The company is listed on BSE.


Below you will find details about Zenotech Laboratories Company Profile, Share Price, News, Address, Management, Registrar and Contact Details.
 

Indutry Type

Pharma
 

Year of Incorporation

1989
 

Registered Address

Survey No. 250-252,
Turkapally Village,,Shameerpet Mandal,
Hyderabad
Andhra Pradesh
500078
Tel: 040-23480431 040-23480432
Fax: 040-23480429

 

Corporate Contact Details

 

Company Registrar

Karvy Computershare Private Ltd. "Karvy House"
46, Avenue 4,
Street No. 1,
Banjara Hills
Tel: 040-23312454, 23320251/751/752
Fax: 040-23311968

 

Company Management

Name : Designation
Sudershan K Arora : Executive Chairman
Jayaram Chigurupati : Director
Name : Designation
B K Raizada : Managing Director
A Raghu Vasu : Director

 

Jobs

 

Similar Companies

 
 
 
 
 
 
Post Your Reviews / Comments / Queries
Name :
Email :
Mobile :
(Your Email and Mobile will not be shared with anyone. It is just for replying to your comments / queries / questions. Your Queries will be answered by indiasite.com experts.)
Please Post your Reviews / Comments / Queries :
(Max 700 Characters allowed)
   




About us |  Contact us |  Privacy Policy |  Terms And Conditions |  Advertise with us
Copyright © : indiasite.com (All rights reserved)